Grik5 Protein Glutamate Receptor Kainate Type Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GRIK5 (Glutamate Receptor Kainate Type Subunit 5), also known as KA2 (Kainate Receptor 2), is an ionotropic glutamate receptor subunit that forms functional kainate receptors when combined with other GRIK subunits. Kainate receptors play important roles in excitatory neurotransmission, synaptic plasticity, and neuronal development. [@contractor2011]
Protein Information
Structure
GRIK5 is composed of:
N-terminal domain (ATD): Affects receptor assembly and trafficking
Ligand-binding domain (LBD): Binds glutamate and kainate agonists
Transmembrane domain (TMD): Three membrane-spanning helices + pore loop
C-terminal domain (CTD): Postsynaptic density interactions, phosphorylation sites
GRIK5 typically forms heteromeric receptors with GRIK2 or GRIK3 subunits, as it cannot form functional homomeric channels on its own.
Normal Function
Excitatory Neurotransmission
Mediates slow depolarizing responses to glutamate
Contributes to synaptic integration in hippocampal and cortical [neurons](/entities/neurons)
Modulates neuronal excitability
Synaptic Plasticity
Involved in both [LTP](/mechanisms/long-term-potentiation) and LTD at certain synapses
Regulates presynaptic release probability
Contributes to activity-dependent synaptic remodeling
Neuronal Development
Regulates neurite outgrowth andaxon guidance
Influences synapse formation during development
Critical period plasticity in visual [cortex](/brain-regions/cortex)
Kainate receptors in epilepsy - Brain (2014) - PMID: 24578528(https://pubmed.ncbi.nlm.nih.gov/24578528/)
Therapeutic potential of kainate receptor modulators - Nat Rev Drug Discov (2016) - PMID: 27007924(https://pubmed.ncbi.nlm.nih.gov/27007924/)
Background
The study of Grik5 Protein Glutamate Receptor Kainate Type Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.